HEADER PROTEIN FIBRIL 02-OCT-19 6SZF TITLE SOLUTION STRUCTURE OF THE AMYLOID BETA-PEPTIDE (1-42) COMPND MOL_ID: 1; COMPND 2 MOLECULE: AMYLOID-BETA PRECURSOR PROTEIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: APP,ABPP,APPI,ALZHEIMER DISEASE AMYLOID PROTEIN,AMYLOID COMPND 5 PRECURSOR PROTEIN,AMYLOID-BETA A4 PROTEIN,CEREBRAL VASCULAR AMYLOID COMPND 6 PEPTIDE,CVAP,PREA4,PROTEASE NEXIN-II,PN-II; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: APP, A4, AD1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS AMYLOID, ALZHEIMER'S DISEASE, AB42, PROTEIN FIBRIL EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR M.GRIMALDI,A.SANTORO,I.STILLITANO,M.BUONOCORE,A.M.D'URSI REVDAT 5 14-JUN-23 6SZF 1 REMARK REVDAT 4 22-SEP-21 6SZF 1 JRNL REVDAT 3 11-AUG-21 6SZF 1 JRNL REVDAT 2 04-AUG-21 6SZF 1 JRNL REVDAT 1 14-OCT-20 6SZF 0 JRNL AUTH A.SANTORO,M.GRIMALDI,M.BUONOCORE,I.STILLITANO,A.M.D'URSI JRNL TITL EXPLORING THE EARLY STAGES OF THE AMYLOID A BETA (1-42) JRNL TITL 2 PEPTIDE AGGREGATION PROCESS: AN NMR STUDY. JRNL REF PHARMACEUTICALS V. 14 2021 JRNL REFN ESSN 1424-8247 JRNL PMID 34451828 JRNL DOI 10.3390/PH14080732 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 2.1 REMARK 3 AUTHORS : GUNTERT P. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6SZF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-OCT-19. REMARK 100 THE DEPOSITION ID IS D_1292104612. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 300 REMARK 210 PH : 5.4 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : AMBIENT ATM REMARK 210 SAMPLE CONTENTS : 0.5 MM AMYLOID BETA-PEPTIDE (1 REMARK 210 -42), 50% H2O/50% HFIP REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H NOESY; 2D 1H-1H TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA 2.1, SPARKY REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 4490 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLU A 11 65.10 -114.32 REMARK 500 1 VAL A 12 -157.40 -144.35 REMARK 500 1 PHE A 20 -33.34 177.83 REMARK 500 1 ASP A 23 -36.22 -176.98 REMARK 500 1 LYS A 28 127.84 67.23 REMARK 500 1 VAL A 36 -39.11 -162.42 REMARK 500 1 VAL A 39 -65.81 -134.74 REMARK 500 1 ILE A 41 -59.23 -136.91 REMARK 500 2 VAL A 12 -158.25 -109.94 REMARK 500 2 LYS A 16 -28.69 176.97 REMARK 500 2 PHE A 19 49.29 -83.77 REMARK 500 2 PHE A 20 -34.03 179.94 REMARK 500 2 GLU A 22 56.28 -91.11 REMARK 500 2 ASP A 23 -36.04 -177.46 REMARK 500 2 LYS A 28 127.90 67.22 REMARK 500 2 VAL A 36 -39.03 -162.33 REMARK 500 2 VAL A 39 -69.40 -132.99 REMARK 500 3 GLU A 11 50.50 -115.72 REMARK 500 3 VAL A 12 -157.45 -122.99 REMARK 500 3 PHE A 20 19.50 -152.31 REMARK 500 3 ASP A 23 32.51 -174.21 REMARK 500 3 SER A 26 50.95 -92.71 REMARK 500 3 LYS A 28 128.01 67.25 REMARK 500 3 ILE A 31 34.66 -140.52 REMARK 500 3 VAL A 36 -50.69 -163.65 REMARK 500 3 VAL A 39 -75.00 -146.35 REMARK 500 4 HIS A 6 -70.17 -57.38 REMARK 500 4 ASP A 7 -70.43 71.63 REMARK 500 4 VAL A 12 -154.49 -99.74 REMARK 500 4 LYS A 16 -28.77 176.94 REMARK 500 4 PHE A 20 19.67 -152.67 REMARK 500 4 ASP A 23 -38.24 -176.45 REMARK 500 4 LYS A 28 127.82 67.22 REMARK 500 4 ILE A 31 36.08 -141.24 REMARK 500 4 VAL A 36 -39.08 -162.53 REMARK 500 4 VAL A 39 -51.51 -132.03 REMARK 500 4 ILE A 41 -51.79 -133.59 REMARK 500 5 VAL A 12 -154.28 -100.02 REMARK 500 5 PHE A 20 -32.93 176.89 REMARK 500 5 ASP A 23 -35.85 -177.73 REMARK 500 5 LYS A 28 127.98 67.21 REMARK 500 5 VAL A 36 -39.06 -162.43 REMARK 500 6 GLU A 11 65.20 -114.33 REMARK 500 6 VAL A 12 -157.41 -144.45 REMARK 500 6 PHE A 20 19.50 -152.31 REMARK 500 6 ASP A 23 -40.99 -176.57 REMARK 500 6 SER A 26 77.28 -115.65 REMARK 500 6 ASN A 27 36.06 -97.22 REMARK 500 6 LYS A 28 -158.34 -130.22 REMARK 500 6 ALA A 30 -33.76 -174.78 REMARK 500 REMARK 500 THIS ENTRY HAS 88 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34440 RELATED DB: BMRB REMARK 900 SOLUTION STRUCTURE OF THE AMYLOID BETA-PEPTIDE (1-42) DBREF 6SZF A 1 42 UNP P05067 A4_HUMAN 672 713 SEQRES 1 A 42 ASP ALA GLU PHE ARG HIS ASP SER GLY TYR GLU VAL HIS SEQRES 2 A 42 HIS GLN LYS LEU VAL PHE PHE ALA GLU ASP VAL GLY SER SEQRES 3 A 42 ASN LYS GLY ALA ILE ILE GLY LEU MET VAL GLY GLY VAL SEQRES 4 A 42 VAL ILE ALA HELIX 1 AA1 LEU A 17 GLY A 25 1 9 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1